Reporting Hub
2022

Novartis in Society Integrated Report 2022

The Novartis in Society Integrated Report provides an overview of our business, strategy and performance during 2022. It also describes how we create value for stakeholders and society.

Back cover photo of annual reports (Photo)

Regulatory disclosures

Our Annual Report 2022 filed with the SIX Swiss Exchange, and our Form 20-F 2022 filed with the US Securities & Exchange Commission.

Further disclosures and reporting archive

Access our reporting archive and other disclosures.

Topic filter

Results

Welcome to our topic filter! Please select one or more topics and navigate to pages in the report that are of interest to you.
Introduction 2022 at a glance
Introduction Chair’s letter
Introduction CEO’s letter
Who we are Our company
Who we are Our medicines
Who we are Our global operations
Who we are Our people, culture and values
Business environment Our business environment
Business environment Our material issues
Strategy and value creation Our strategy
Strategy and value creation How we create value
Strategy and value creation Stakeholder engagement
Strategy and value creation Measuring our impact
Performance in 2022 Financial performance
Performance in 2022 Deliver high-value medicines
Performance in 2022 Embed operational excellence
Performance in 2022 Unleash the power of our people
Performance in 2022 Scale data science and technology
Performance in 2022 Build trust with society
Governance Corporate governance
Governance Ethics, risk and compliance
Governance Compensation Report
Appendices TCFD disclosure
Novartis in Society Performance indicators

Reporting Hub 2022